检索结果-内蒙古大学图书馆

Drivers of the Sustainability Performance of Induction Stove Conversion program in Indonesia

International Journal of Sustainable Energy Planning and Management 2025年 43卷 5-30页

作者： Damayanti, Retno Wulan Safira, Silvia Dhea Laksono, Pringgo Widyo Setiadi, Haryono Entifar, Nisa Aqilla Ellenahaya Industrial Engineering Study Program Sebelas Maret University Ir.Sutami 36A Surakarta57121 – 57162 Indonesia Center of Technology Development and Industrial Collaboration Institute for Research and Community Service Sebelas Maret University Ir.Sutami 36A Surakarta57121 – 57162 Indonesia Informatics and Science Data Study Program Sebelas Maret University Ir.Sutami 36A Surakarta57121 – 57162 Indonesia Smart Green Technology Engineering Department Pukyong National University 45 Yongso-ro Nam-Gu Busan Korea Republic of

In 2022, Indonesia initiated a pilot project to transition from liquid petroleum gas (LPG) stoves to induction stoves, targeting 8.2 million households by 2025. While LPG is considered a clean cooking fuel by the World Health Organization due to its low PM2.5 emissions, this program aims to further reduce CO2 emissions from cooking activities, aligning with Indonesia’s clean energy transition and 2060 Net Zero Emission goals. Throughout the program, doubts and criticisms arose among various sectors of society, particularly concerning the sustainability of this program. This research aims to determine and analyze the driving factors that support the sustainability of the induction stove transition program. Five sustainability aspects, namely, economic, social, environmental, technical, and institutional, were analyzed. A total of 315 Indonesian citizens participated as respondents in this research survey. The Partial Least Squares-Structural Equation Model (PLS–SEM) method was utilized as the analytical approach for the study. The results revealed that nine factors significantly influenced program sustainability, with the strongest impacts from technology costs (path coefficient = 0.859), contextual factors (0.803), electrical infrastructure (0.792), and community perception (0.773). Economic sustainability was driven by technology costs and business opportunities (0.643), while environmental sustainability was strongly influenced by electrical infrastructure. Post-installation support (0.307) and financial management (0.391) significantly impacted technical and institutional sustainability respectively. These empirical findings improve previous research on the sustainability of an energy transition program, which provides insights for researchers and stakeholders in the energy management field, especially in developing countries, for policy determination and decision-making. © 2025, Aalborg University Press. All rights reserved.

关键词： Clean energy

来源：评论

学校读者我要写书评

暂无评论

Herb compounds screening as meningitis inhibitor candidates using neural network and random forest methods

引用

AIP Conference Proceedings 2025年第1期3250卷

作者： Riska Aprilia Mohammad Hamim Zajuli Al Faroby Muhammad Adib Kamali Muhammad Dzulfikar Fauzi Information Technology Study Program Faculty of Information Technology and Business Institut Teknologi Telkom Surabaya Surabaya Indonesia Data Science Study Program Faculty of Information Technology and Business Institut Teknologi Telkom Surabaya Surabaya Indonesia Informatics Study Program Faculty of Information Technology and Business Institut Teknologi Telkom Surabaya Surabaya Indonesia

Meningitis is an inflammation of the meninges that occurs in the protective lining of the brain and spinal cord caused by bacterial, viral, or fungal infections. This disease is difficult to recognize because it has initial symptoms like the flu where the patient has a fever and headache. Current efforts to prevent the disease by strengthening antibodies. Meanwhile, drug candidates for the treatment of this disease still have not found optimal results in reducing mortality due to meningitis. This study aims to find and analyses herbal compound candidates that might be inhibitors of meningitis. Compound data was acquired from a validated open database. The data acquired are smiles of the chemical bond structure of the compounds. In the data processing process, compound feature extraction is required by applying the concept of molecular fingerprint. The results of feature extraction are used as datasets to build classification models by applying the Multilayer Perceptron (MLP) and Random Forest algorithms. The two models are compared, and a more robust model is selected to be used as a prediction model for herbal compound search. The MLP model has a better accuracy of 0.97 compared to the Random Forest model. The results of screening using the MLP learning model obtained Symphytine, cis-Linalool oxide, and 3-O-Methylcalopocarpin compounds have the highest probability compared to thousands of other herbal compounds. This candidate compound can be used as a recommendation for drug discovery to treat patients who contract Meningitis.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

arXiv

引用

arXiv 2025年

作者： Huang, Yepeng Su, Xiaorui Ullanat, Varun Liang, Ivy Clegg, Lindsay Olabode, Damilola Ho, Nicholas John, Bino Gibbs, Megan Zitnik, Marinka Department of Biomedical Informatics Harvard Medical School BostonMA United States Program in Biological and Biomedical Sciences Harvard Medical School BostonMA United States Harvard College CambridgeMA United States Clinical Pharmacology and Quantitative Pharmacology Clinical Pharmacology & Safety Sciences R&D AstraZeneca GaithersburgMD United States Clinical Pharmacology and Quantitative Pharmacology Clinical Pharmacology & Safety Sciences R&D AstraZeneca WalthamMA United States Program in Computational Biology Carnegie Mellon University PittsburghPA United States Imaging and Data Analytics Clinical Pharmacology & Safety Sciences R&D AstraZeneca WalthamMA United States Kempner Institute for the Study of Natural and Artificial Intelligence Harvard University AllstonMA United States Broad Institute of MIT and Harvard CambridgeMA United States Harvard Data Science Initiative CambridgeMA United States

Predicting clinical outcomes from preclinical data is essential for identifying safe and effective drug combinations, reducing late-stage clinical failures, and accelerating the development of precision therapies. Current models rely on structural or target-based features to identify high-efficacy, low-toxicity drug combinations. However, these approaches fail to incorporate the multimodal data necessary for accurate, clinically-relevant predictions. Here, we introduce MADRIGAL, a multimodal AI model that learns from structural, pathway, cell viability, and transcriptomic data to predict drug combination effects across 953 clinical outcomes and 21,842 compounds, including combinations of approved drugs and novel compounds in development. MADRIGAL uses a transformer bottleneck module to unify preclinical drug data modalities while handling missing data during training and inference—a major challenge in multimodal learning. It outperforms single-modality methods and state-of-the-art models in predicting adverse drug interactions. MADRIGAL performs virtual screening of anticancer drug combinations and supports polypharmacy management for type II diabetes and metabolic dysfunction-associated steatohepatitis (MASH). It identifies transporter-mediated drug interactions. MADRIGAL predicts resmetirom, the first and only FDA-approved drug for MASH, among therapies with the most favorable safety profile. It supports personalized cancer therapy by integrating genomic profiles from cancer patients. Using primary acute myeloid leukemia samples and patient-derived xenograft models, it predicts the efficacy of personalized drug combinations. Integrating MADRIGAL with a large language model allows users to describe clinical outcomes in natural language, improving safety assessment by identifying potential adverse interactions and toxicity risks. MADRIGAL provides a multimodal approach for designing combination therapies with improved predictive accuracy and clinical relevance. Copy

关键词： Diseases

来源：评论

学校读者我要写书评

暂无评论

Empowering Biomedical Discovery with AI Agents

arXiv

引用

arXiv 2024年

作者： Gao, Shanghua Fang, Ada Huang, Yepeng Giunchiglia, Valentina Noori, Ayush Schwarz, Jonathan Richard Ektefaie, Yasha Kondic, Jovana Zitnik, Marinka Department of Biomedical Informatics Harvard Medical School BostonMA United States Department of Chemistry and Chemical Biology Harvard University CambridgeMA United States Program in Biological and Biomedical Sciences Harvard Medical School BostonMA United States Department of Brain Sciences Imperial College London London United Kingdom Harvard College CambridgeMA United States Program in Biomedical Informatics Harvard Medical School BostonMA United States Department of Electrical Engineering and Computer Science MIT CambridgeMA United States Kempner Institute for the Study of Natural and Artificial Intelligence Harvard University MA United States Broad Institute of MIT and Harvard CambridgeMA United States Harvard Data Science Initiative CambridgeMA United States

We envision "AI scientists" as systems capable of skeptical learning and reasoning that empower biomedical research through collaborative agents that integrate AI models and biomedical tools with experimental platforms. Rather than taking humans out of the discovery process, biomedical AI agents combine human creativity and expertise with AI’s ability to analyze large datasets, navigate hypothesis spaces, and execute repetitive tasks. AI agents are poised to be proficient in various tasks, planning discovery workflows and performing self-assessment to identify and mitigate gaps in their knowledge. These agents use large language models and generative models to feature structured memory for continual learning and use machine learning tools to incorporate scientific knowledge, biological principles, and theories. AI agents can impact areas ranging from virtual cell simulation, programmable control of phenotypes, and the design of cellular circuits to developing new therapies. © 2024, CC BY.

关键词： Adversarial machine learning

来源：评论

学校读者我要写书评

暂无评论

Graph Artificial Intelligence in Medicine

引用

Biomedical data science 1000年第1期7卷 345-368页

作者： Ruth Johnson Michelle M. Li Ayush Noori Owen Queen Marinka Zitnik 1Department of Biomedical Informatics Harvard Medical School Boston Massachusetts USA email: marinka@hms.harvard.edu 2Berkowitz Family Living Laboratory Harvard Medical School Boston Massachusetts USA 3Bioinformatics and Integrative Genomics Program Harvard Medical School Boston Massachusetts USA 4Department of Computer Science Harvard John A. Paulson School of Engineering and Applied Sciences Allston Massachusetts USA 5Broad Institute of MIT and Harvard Cambridge Massachusetts USA 7Kempner Institute for the Study of Natural and Artificial Intelligence Harvard University Allston Massachusetts USA 6Harvard Data Science Initiative Cambridge Massachusetts USA

In clinical artificial intelligence (AI), graph representation learning, mainly through graph neural networks and graph transformer architectures, stands out for its capability to capture intricate relationships and structures within clinical datasets. With diverse data—from patient records to imaging—graph AI models process data holistically by viewing modalities and entities within them as nodes interconnected by their relationships. Graph AI facilitates model transfer across clinical tasks, enabling models to generalize across patient populations without additional parameters and with minimal to no retraining. However, the importance of human-centered design and model interpretability in clinical decision-making cannot be overstated. Since graph AI models capture information through localized neural transformations defined on relational datasets, they offer both an opportunity and a challenge in elucidating model rationale. Knowledge graphs can enhance interpretability by aligning model-driven insights with medical knowledge. Emerging graph AI models integrate diverse data modalities through pretraining, facilitate interactive feedback loops, and foster human–AI collaboration, paving the way toward clinically meaningful predictions.

关键词：

来源：评论

学校读者我要写书评

暂无评论

Graph AI in Medicine

arXiv

引用

arXiv 2023年

作者： Johnson, Ruth Li, Michelle M. Noori, Ayush Queen, Owen Zitnik, Marinka Department of Biomedical Informatics Harvard Medical School BostonMA02115 United States Berkowitz Family Living Laboratory Harvard Medical School BostonMA02115 United States Bioinformatics and Integrative Genomics Program Harvard Medical School BostonMA02115 United States Harvard College CambridgeMA02138 United States Broad Institute of MIT and Harvard CambridgeMA02142 United States Harvard Data Science Initiative CambridgeMA02138 United States Kempner Institute for the Study of Natural and Artificial Intelligence Harvard University AllstonMA United States

In clinical artificial intelligence (AI), graph representation learning, mainly through graph neural networks and graph transformer architectures, stands out for its capability to capture intricate relationships and structures within clinical datasets. With diverse data-from patient records to imaging-graph AI models process data holistically by viewing modalities and entities within them as nodes interconnected by their relationships. Graph AI facilitates model transfer across clinical tasks, enabling models to generalize across patient populations without additional parameters or minimal to no re-training. However, the importance of human-centered design and model interpretability in clinical decision-making cannot be overstated. Since graph AI models capture information through localized neural transformations defined on relational datasets, they offer both an opportunity and a challenge in elucidating model rationale. Knowledge graphs can enhance interpretability by aligning model-driven insights with medical knowledge. Emerging graph AI models integrate diverse data modalities through pre-training, facilitate interactive feedback loops, and foster human-AI collaboration, paving the way to clinically meaningful predictions. © 2023, CC BY.

关键词： Knowledge graph

来源：评论

学校读者我要写书评

暂无评论

Whole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele

引用

Nature communications 2025年第1期16卷 3470-3470页

作者： Zhang, Xinruo Brody, Jennifer A. Graff, Mariaelisa Highland, Heather M. Chami, Nathalie Xu, Hanfei Wang, Zhe Ferrier, Kendra R. Chittoor, Geetha Josyula, Navya Shilpa Meyer, Mariah Gupta, Shreyash Li, Xihao Li, Zilin Allison, Matthew A. Becker, Diane M. Bielak, Lawrence F. Bis, Joshua C. Boorgula, Meher Preethi Bowden, Donald W. Broome, Jai G. Buth, Erin J. Carlson, Christopher S. Chang, Kyong-Mi Chavan, Sameer Chiu, Yen-Feng Chuang, Lee-Ming Conomos, Matthew P. DeMeo, Dawn L. Du, Mengmeng Duggirala, Ravindranath Eng, Celeste Fohner, Alison E. Freedman, Barry I. Garrett, Melanie E. Guo, Xiuqing Haiman, Chris Heavner, Benjamin D. Hidalgo, Bertha Hixson, James E. Ho, Yuk-Lam Hobbs, Brian D. Hu, Donglei Hui, Qin Hwu, Chii-Min Jackson, Rebecca D. Jain, Deepti Kalyani, Rita R. Kardia, Sharon L R Kelly, Tanika N. Lange, Ethan M. LeNoir, Michael Li, Changwei Le Marchand, Loic McDonald, Merry-Lynn N McHugh, Caitlin P. Morrison, Alanna C. Naseri, Take Palmer, Nicholette D. Pankow, James S. Perry, James A. Peters, Ulrike Preuss, Michael H. Rao, D.C. Regan, Elizabeth A. Reupena, Sefuiva M. Roden, Dan M. Rodriguez-Santana, Jose Sitlani, Colleen M. Smith, Jennifer A. Tiwari, Hemant K. Vasan, Ramachandran S. Wang, Zeyuan Weeks, Daniel E. Wessel, Jennifer Wiggins, Kerri L. Wilkens, Lynne R. Wilson, Peter W F Yanek, Lisa R. Yoneda, Zachary T. Zhao, Wei Zöllner, Sebastian Arnett, Donna K. Ashley-Koch, Allison E. Barnes, Kathleen C. Blangero, John Boerwinkle, Eric Burchard, Esteban G. Carson, April P. Chasman, Daniel I. Ida Chen, Yii-Der Curran, Joanne E. Fornage, Myriam Gordeuk, Victor R. He, Jiang Heckbert, Susan R. Hou, Lifang Irvin, Marguerite R. Kooperberg, Charles Minster, Ryan L. Mitchell, Braxton D. Nouraie, Mehdi Psaty, Bruce M. Raffield, Laura M. Reiner, Alexander P. Rich, Stephen S. Rotter, Jerome I. Benjamin Shoemaker, M. Smith, Nicholas L. Taylor, Kent D. Telen, Marilyn J. Weiss, Scott T. Zhang, Yingze Heard-Costa, Nancy Sun, Yan V. Lin, Xihong Cupples, L Adrienne Lange, Leslie A. Liu, Ching-Ti Loos, Ruth J F North, K Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill Chapel Hill NC United States Cardiovascular Health Research Unit Department of Medicine University of Washington Seattle WA United States The Charles Bronfman Institute for Personalized Medicine Icahn School of Medicine at Mount Sinai New York NY USA The Mindich Child Health and Development Institute Icahn School of Medicine at Mount Sinai New York NY USA Department of Biostatistics School of Public Health Boston University Boston MA United States Division of Biomedical Informatics and Personalized Medicine University of Colorado School of Medicine Anschutz Medical Campus Aurora CO United States Population Health Sciences Geisinger Danville PA United States Department of Biostatistics Harvard T.H. Chan School of Public Health Boston MA United States Department of Biostatistics Gillings School of Global Public Health University of North Carolina at Chapel Hill Chapel Hill NC United States Department of Genetics School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC United States Biostatistics and Health Data Science Indiana University School of Medicine Indianapolis IN United States School of Mathematics and Statistics and KLAS Northeast Normal University Changchun Jilin China Department of Family Medicine Division of Preventive Medicine University of California San Diego La Jolla CA United States Department of Medicine General Internal Medicine Johns Hopkins University School of Medicine Baltimore MD United States Department of Epidemiology School of Public Health University of Michigan Ann Arbor MI United States Department of Medicine University of Colorado School of Medicine Aurora CO United States Department of Biochemistry Wake Forest School of Medicine Winston-Salem NC United States Department of Biostatistics School of Public Health University of Washington Seattle WA United States Department of

Obesity is a major public health crisis associated with high mortality rates. Previous genome-wide association studies (GWAS) investigating body mass index (BMI) have largely relied on imputed data from European individuals. This study leveraged whole-genome sequencing (WGS) data from 88,873 participants from the Trans-Omics for Precision Medicine (TOPMed) program, of which 51% were of non-European population groups. We discovered 18 BMI-associated signals (P < 5 × 10-9), including two secondary signals. Notably, we identified and replicated a novel low-frequency single nucleotide polymorphism (SNP) in MTMR3 that was common in individuals of African descent. Using a diverse study population, we further identified two novel secondary signals in known BMI loci and pinpointed two likely causal variants in the POC5 and DMD loci. Our work demonstrates the benefits of combining WGS and diverse cohorts in expanding current catalog of variants and genes confer risk for obesity, bringing us one step closer to personalized medicine. © 2025. The Author(s).

关键词：

来源：评论

学校读者我要写书评

暂无评论

Scientific discovery in the age of artificial intelligence

引用

NATURE 2023年第7978期621卷 E33-E33页

作者： Wang, Hanchen Fu, Tianfan Du, Yuanqi Gao, Wenhao Huang, Kexin Liu, Ziming Chandak, Payal Liu, Shengchao Van Katwyk, Peter Deac, Andreea Anandkumar, Anima Bergen, Karianne Gomes, Carla P. Ho, Shirley Kohli, Pushmeet Lasenby, Joan Leskovec, Jure Liu, Tie-Yan Manrai, Arjun Marks, Debora Ramsundar, Bharath Song, Le Sun, Jimeng Tang, Jian Velickovic, Petar Welling, Max Zhang, Linfeng Coley, Connor W. Bengio, Yoshua Zitnik, Marinka Department of Engineering University of Cambridge Cambridge UK Department of Computing and Mathematical Sciences California Institute of Technology Pasadena CA USA NVIDIA Santa Clara CA USA Department of Computational Science and Engineering Georgia Institute of Technology Atlanta GA USA Department of Computer Science Cornell University Ithaca NY USA Department of Chemical Engineering Massachusetts Institute of Technology Cambridge MA USA Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology Cambridge MA USA Department of Computer Science Stanford University Stanford CA USA Department of Physics Massachusetts Institute of Technology Cambridge MA USA Harvard-MIT Program in Health Sciences and Technology Cambridge MA USA Mila – Quebec AI Institute Montreal Quebec Canada Université de Montréal Montreal Quebec Canada HEC Montréal Montreal Quebec Canada CIFAR AI Chair Toronto Ontario Canada Department of Earth Environmental and Planetary Sciences Brown University Providence RI USA Data Science Institute Brown University Providence RI USA Center for Computational Astrophysics Flatiron Institute New York NY USA Department of Astrophysical Sciences Princeton University Princeton NJ USA Department of Physics Carnegie Mellon University Pittsburgh PA USA Department of Physics and Center for Data Science New York University New York NY USA Google DeepMind London UK Department of Computer Science and Technology University of Cambridge Cambridge UK Microsoft Research Beijing China Department of Biomedical Informatics Harvard Medical School Boston MA USA Broad Institute of MIT and Harvard Cambridge MA USA Harvard Data Science Initiative Cambridge MA USA Kempner Institute for the Study of Natural and Artificial Intelligence Harvard University Cambridge MA USA Department of Systems Biology Harvard Medical School Boston MA USA Deep Forest Sciences Palo Alto CA USA BioMap Beijing China Mo

来源：评论

学校读者我要写书评

暂无评论

BigNeuron: a resource to benchmark and predict performance of algorithms for automated tracing of neurons in light microscopy datasets

引用

Nature methods 2023年第6期20卷 824-835页

作者： Linus Manubens-Gil Zhi Zhou Hanbo Chen Arvind Ramanathan Xiaoxiao Liu Yufeng Liu Alessandro Bria Todd Gillette Zongcai Ruan Jian Yang Miroslav Radojević Ting Zhao Li Cheng Lei Qu Siqi Liu Kristofer E Bouchard Lin Gu Weidong Cai Shuiwang Ji Badrinath Roysam Ching-Wei Wang Hongchuan Yu Amos Sironi Daniel Maxim Iascone Jie Zhou Erhan Bas Eduardo Conde-Sousa Paulo Aguiar Xiang Li Yujie Li Sumit Nanda Yuan Wang Leila Muresan Pascal Fua Bing Ye Hai-Yan He Jochen F Staiger Manuel Peter Daniel N Cox Michel Simonneau Marcel Oberlaender Gregory Jefferis Kei Ito Paloma Gonzalez-Bellido Jinhyun Kim Edwin Rubel Hollis T Cline Hongkui Zeng Aljoscha Nern Ann-Shyn Chiang Jianhua Yao Jane Roskams Rick Livesey Janine Stevens Tianming Liu Chinh Dang Yike Guo Ning Zhong Georgia Tourassi Sean Hill Michael Hawrylycz Christof Koch Erik Meijering Giorgio A Ascoli Hanchuan Peng Institute for Brain and Intelligence Southeast University Nanjing China. Microsoft Corporation Redmond WA USA. Tencent AI Lab Bellevue WA USA. Computing Environment and Life Sciences Directorate Argonne National Laboratory Lemont IL USA. Kaya Medical Seattle WA USA. University of Cassino and Southern Lazio Cassino Italy. Center for Neural Informatics Structures and Plasticity Krasnow Institute for Advanced Study George Mason University Fairfax VA USA. Faculty of Information Technology Beijing University of Technology Beijing China. Beijing International Collaboration Base on Brain Informatics and Wisdom Services Beijing China. Nuctech Netherlands Rotterdam the Netherlands. Janelia Research Campus Howard Hughes Medical Institute Ashburn VA USA. Department of Electrical and Computer Engineering University of Alberta Edmonton Alberta Canada. Ministry of Education Key Laboratory of Intelligent Computation and Signal Processing Anhui University Hefei China. Paige AI New York NY USA. Scientific Data Division and Biological Systems and Engineering Division Lawrence Berkeley National Lab Berkeley CA USA. Helen Wills Neuroscience Institute and Redwood Center for Theoretical Neuroscience UC Berkeley Berkeley CA USA. RIKEN AIP Tokyo Japan. Research Center for Advanced Science and Technology (RCAST) The University of Tokyo Tokyo Japan. School of Computer Science University of Sydney Sydney New South Wales Australia. Texas A&M University College Station TX USA. Cullen College of Engineering University of Houston Houston TX USA. Graduate Institute of Biomedical Engineering National Taiwan University of Science and Technology Taipei Taiwan. National Centre for Computer Animation Bournemouth University Poole UK. PROPHESEE Paris France. Department of Neuroscience Columbia University New York NY USA. Mortimer B. Zuckerman Mind Brain Behavior Institute Columbia University New York NY USA. Department of Computer Science Northern Illinois Universit

BigNeuron is an open community bench-testing platform with the goal of setting open standards for accurate and fast automatic neuron tracing. We gathered a diverse set of image volumes across several species that is representative of the data obtained in many neuroscience laboratories interested in neuron tracing. Here, we report generated gold standard manual annotations for a subset of the available imaging datasets and quantified tracing quality for 35 automatic tracing algorithms. The goal of generating such a hand-curated diverse dataset is to advance the development of tracing algorithms and enable generalizable benchmarking. Together with image quality features, we pooled the data in an interactive web application that enables users and developers to perform principal component analysis, t-distributed stochastic neighbor embedding, correlation and clustering, visualization of imaging and tracing data, and benchmarking of automatic tracing algorithms in user-defined data subsets. The image quality metrics explain most of the variance in the data, followed by neuromorphological features related to neuron size. We observed that diverse algorithms can provide complementary information to obtain accurate results and developed a method to iteratively combine methods and generate consensus reconstructions. The consensus trees obtained provide estimates of the neuron structure ground truth that typically outperform single algorithms in noisy datasets. However, specific algorithms may outperform the consensus tree strategy in specific imaging conditions. Finally, to aid users in predicting the most accurate automatic tracing results without manual annotations for comparison, we used support vector machine regression to predict reconstruction quality given an image volume and a set of automatic tracings.

关键词：

来源：评论

学校读者我要写书评

暂无评论

The science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health Disparities

JACC: Advances

引用

JACC: Advances 2024年第1期3卷 100759-100759页

作者： Pearson, Thomas A. Vitalis, Debbie Pratt, Charlotte Campo, Rebecca Armoundas, Antonis A. Au, David Beech, Bettina Brazhnik, Olga Chute, Christopher G. Davidson, Karina W. Diez-Roux, Ana V. Fine, Lawrence J. Gabriel, Davera Groenveld, Peter Hall, Jaclyn Hamilton, Alison B. Hu, Hui Ji, Heng Kind, Amy Kraus, William E. Krumholz, Harlan Mensah, George A. Merchant, Raina M. Mozaffarian, Dariush Murray, David M. Neumark-Sztainer, Dianne Petersen, Maya Goff, David College of Medicine and College of Public Health and Health Professions University of Florida Health Science Center Gainesville FL United States Division of Cardiovascular Sciences National Heart Lung and Blood Institute National Institutes of Health Bethesda MD United States Cardiovascular Research Center Massachusetts General Hospital and Broad Institute Massachusetts Institute of Technology Cambridge MA United States Center of Innovation for Veteran-Centered and Value-Driven Care University of Washington Seattle WA United States UH Population Health University of Houston Houston TX United States Johns Hopkins Medicine Institute for Clinical and Translational Research Baltimore MD United States Institute of Health System Science Feinstein Institutes for Medical Research Northwell Health New Hyde Park NY United States Feinstein Institutes for Medical Research Northwell Health Manhasset NY United States Urban Health Collaborative Drexel Dornsife School of Public Health Philadelphia PA United States Biomedical Informatics and Data Science Section Johns Hopkins University School of Medicine Baltimore MD United States Center for Health Care Transformation and Innovation University of Pennsylvania Perelman School of Medicine Philadelphia PA United States Department of Health Outcomes and Biomedical Informatics Institute for Child Health Policy College of Medicine University of Florida Gainesville FL United States Center for the Study of Healthcare Innovation Implementation & Policy VA Greater Los Angeles Healthcare System Los Angeles CA United States Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA United States Department of Computer Science University of Illinois Urbana-Champaign Champaign IL United States Center for Health Disparities Research (CHDR) University of Wisconsin School of Medicine and Public Health Madison WI United States Duke Molecular Physiology Insti

Precision prevention embraces personalized prevention but includes broader factors such as social determinants of health to improve cardiovascular health. The quality, quantity, precision, and diversity of data relatable to individuals and communities continue to expand. New analytical methods can be applied to these data to create tools to attribute risk, which may allow a better understanding of cardiovascular health disparities. Interventions using these analytic tools should be evaluated to establish feasibility and efficacy for addressing cardiovascular disease disparities in diverse individuals and communities. Training in these approaches is important to create the next generation of scientists and practitioners in precision prevention. This state-of-the-art review is based on a workshop convened to identify current gaps in knowledge and methods used in precision prevention intervention research, discuss opportunities to expand trials of implementation science to close the health equity gaps, and expand the education and training of a diverse precision prevention workforce. © 2023 The Authors

关键词： data science health equity health promotion implementation science personalized medicine precision analytics

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：